Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy
NCT01909388
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
RADIATION:
MRI-TRUS fusion guided real time HDR
Sponsor
Alfonso Gomez-Iturriaga
Collaborators
[object Object]